Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Nuclear Medicine

  Free Subscription


12.11.2018

7 Ann Nucl Med
2 Appl Radiat Isot
7 Clin Nucl Med
6 J Nucl Cardiol
13 J Nucl Med
3 Nucl Med Commun
1 Phys Med Biol
1 PLoS One
2 Semin Nucl Med
1 Synapse


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Nucl Med

  1. INOUE Y, Nagahara K, Inoki Y, Hara T, et al
    Clinical evaluation of CT radiation dose in whole-body (18)F-FDG PET/CT in relation to scout imaging direction and arm position.
    Ann Nucl Med. 2018 Nov 10. pii: 10.1007/s12149-018-1318.
    PubMed     Text format     Abstract available

  2. PAK K, Nam HY, Shin S, Kim K, et al
    Effects of rs591323 on serotonin transporter availability in healthy male subjects.
    Ann Nucl Med. 2018;32:431-436.
    PubMed     Text format     Abstract available

  3. MAIR C, Warwitz B, Fink K, Scarpa L, et al
    Radiation exposure after (177)Lu-DOTATATE and (177)Lu-PSMA-617 therapy.
    Ann Nucl Med. 2018;32:499-502.
    PubMed     Text format     Abstract available

  4. KATSUURA T, Kitajima K, Fujiwara M, Terada T, et al
    Assessment of tumor response to chemoradiotherapy and predicting prognosis in patients with head and neck squamous cell carcinoma by PERCIST.
    Ann Nucl Med. 2018;32:453-462.
    PubMed     Text format     Abstract available

  5. ISHIWATA K, Ebinuma R, Watanabe C, Hayashi K, et al
    Reliable radiosynthesis of 4-[(10)B]borono-2-[(18)F]fluoro-L-phenylalanine with quality assurance for boron neutron capture therapy-oriented diagnosis.
    Ann Nucl Med. 2018;32:463-473.
    PubMed     Text format     Abstract available

  6. ZHENG S, Chen Z, Huang C, Chen Y, et al
    [(99m)Tc]3PRGD2 for integrin receptor imaging of esophageal cancer: a comparative study with [(18)F]FDG PET/CT.
    Ann Nucl Med. 2018 Nov 3. pii: 10.1007/s12149-018-1315.
    PubMed     Text format     Abstract available

  7. JORAKU A, Hatano K, Kawai K, Kandori S, et al
    Phase I/IIa PET imaging study with (89)zirconium labeled anti-PSMA minibody for urological malignancies.
    Ann Nucl Med. 2018 Nov 7. pii: 10.1007/s12149-018-1312.
    PubMed     Text format     Abstract available


    Appl Radiat Isot

  8. FENG Y, Phipps MD, Phelps TE, Okoye NC, et al
    Evaluation of (72)Se/(72)As generator and production of (72)Se for supplying (72)As as a potential PET imaging radionuclide.
    Appl Radiat Isot. 2018;143:113-122.
    PubMed     Text format     Abstract available

  9. ARTEAGA MV, Caballero VM, Rengifo KM
    Dosimetry of (99m)Tc (DTPA, DMSA and MAG3) used in renal function studies of newborns and children.
    Appl Radiat Isot. 2018;138:25-28.
    PubMed     Text format     Abstract available


    Clin Nucl Med

  10. LEE H, Lee DE, Park S, Kim TS, et al
    Predicting Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: Combined Statistical Modeling Using Clinicopathological Factors and FDG PET/CT Texture Parameters.
    Clin Nucl Med. 2018 Nov 3. doi: 10.1097/RLU.0000000000002348.
    PubMed     Text format     Abstract available

  11. LAI YC, Wu YC, Kao CH, Hsieh TC, et al
    Peritoneal Deciduoid Malignant Mesothelioma on 67Ga SPECT/CT.
    Clin Nucl Med. 2018 Nov 3. doi: 10.1097/RLU.0000000000002363.
    PubMed     Text format     Abstract available

  12. LAI R, Ding C
    18F-FDG PET/CT Imaging in an Adolescent Patient With Primary Prostatic Stromal Sarcoma.
    Clin Nucl Med. 2018 Nov 3. doi: 10.1097/RLU.0000000000002372.
    PubMed     Text format     Abstract available

  13. BAI X, Zhang X, Wang X
    Primary Hepatic Neuroendocrine Tumor: Pretherapy and Posttherapy FDG PET/CT Finding.
    Clin Nucl Med. 2018 Nov 3. doi: 10.1097/RLU.0000000000002376.
    PubMed     Text format     Abstract available

  14. GAO R, Gao S, Jia X, Wang H, et al
    Ectopic Papillary Thyroid Carcinoma Mimicking Esophageal Cancer in FDG PET: A Case Report.
    Clin Nucl Med. 2018 Nov 3. doi: 10.1097/RLU.0000000000002377.
    PubMed     Text format     Abstract available

  15. SUBRAMANIAM RM, Bradshaw ML, Lewis K, Pinho D, et al
    ACR Practice Parameter for the Performance of Gallium-68 DOTATATE PET/CT for Neuroendocrine Tumors.
    Clin Nucl Med. 2018;43:899-908.
    PubMed     Text format     Abstract available

  16. SANLI Y, Zukotynski K, Mittra E, Chen DL, et al
    Update 2018: 18F-FDG PET/CT and PET/MRI in Head and Neck Cancer.
    Clin Nucl Med. 2018;43:e439-e452.
    PubMed     Text format     Abstract available


    J Nucl Cardiol

  17. CHO SG, Lee SJ, Na MH, Choi YY, et al
    Comparison of diagnostic accuracy of PET-derived myocardial blood flow parameters: A meta-analysis.
    J Nucl Cardiol. 2018 Nov 2. pii: 10.1007/s12350-018-01476.
    PubMed     Text format     Abstract available

  18. DEPUEY EG
    Gastric wall uptake of Tc-99m sestamibi: Techniques to decrease uptake and minimize its consequences in myocardial perfusion SPECT.
    J Nucl Cardiol. 2018 Nov 5. pii: 10.1007/s12350-018-01502.
    PubMed     Text format    

  19. MOODY JB, Ficaro EP, Murthy VL
    Simplified quantification PET myocardial blood flow: The need for technical standardization.
    J Nucl Cardiol. 2018 Nov 5. pii: 10.1007/s12350-018-01497.
    PubMed     Text format    

  20. JUAN RAMON A, Yang Y, Wernick MN, Pretorius PH, et al
    Evaluation of the effect of reducing administered activity on assessment of function in cardiac gated SPECT.
    J Nucl Cardiol. 2018 Nov 7. pii: 10.1007/s12350-018-01505.
    PubMed     Text format     Abstract available

  21. LEE BC, Moody JB, Poitrasson-Riviere A, Melvin AC, et al
    Automated dynamic motion correction using normalized gradient fields for (82)rubidium PET myocardial blood flow quantification.
    J Nucl Cardiol. 2018 Nov 7. pii: 10.1007/s12350-018-01471.
    PubMed     Text format     Abstract available

  22. PICCINELLI M, Galt J
    Effect of reduced photon count levels and choice of normal data on semi-automated image assessment in cardiac SPECT: Doing more with fewer counts.
    J Nucl Cardiol. 2018 Nov 8. pii: 10.1007/s12350-018-01499.
    PubMed     Text format    


    J Nucl Med

  23. LI Y, Langhorst J, Koch AK, Demircioglu A, et al
    Assessment of ileocolonic inflammation in Crohn's disease - Which surrogate marker is better? MaRIA, Clermont or PET-MR index? Initial results of a feasibility trial.
    J Nucl Med. 2018 Nov 2. pii: jnumed.118.216937. doi: 10.2967/jnumed.118.216937.
    PubMed     Text format     Abstract available

  24. FREUDENBERG LS, Hicks RJ, Beyer T
    AN INTERNATIONAL SURVEY ON CLINICAL REPORTING OF DUAL-MODALITY PET/CT IMAGING EXAMINATIONS: A STARTING POINT FOR CROSS-SPECIALTY ENGAGEMENT.
    J Nucl Med. 2018 Nov 2. pii: jnumed.118.218073. doi: 10.2967/jnumed.118.218073.
    PubMed     Text format     Abstract available

  25. PERRIN M, Roch V, Claudin M, Verger A, et al
    Assessment of myocardial CZT-SPECT recording in a forward-leaning "biker-like" position.
    J Nucl Med. 2018 Nov 2. pii: jnumed.118.217695. doi: 10.2967/jnumed.118.217695.
    PubMed     Text format     Abstract available

  26. MELLHAMMAR EM, Dahlbom M, Evans-Axelsson S, Strand SE, et al
    Preserving preclinical PET quality during intratherapeutic imaging in radionuclide therapy with Rose metal shielding reducing photon flux.
    J Nucl Med. 2018 Nov 2. pii: jnumed.118.217117. doi: 10.2967/jnumed.118.217117.
    PubMed     Text format     Abstract available

  27. PAPP L, Rausch I, Grahovac M, Hacker M, et al
    Optimized feature extraction for radiomics analysis of (18)F-FDG-PET imaging.
    J Nucl Med. 2018 Nov 2. pii: jnumed.118.217612. doi: 10.2967/jnumed.118.217612.
    PubMed     Text format     Abstract available

  28. WILSON T, Xavier MA, Knight J, Verhoog S, et al
    PET imaging of PARP expression using [(18)F]olaparib.
    J Nucl Med. 2018 Nov 2. pii: jnumed.118.213223. doi: 10.2967/jnumed.118.213223.
    PubMed     Text format     Abstract available

  29. ZLATOPOLSKIY BD, Endepols H, Krapf P, Guliyev M, et al
    Discovery of (18)F-JK-PSMA-7, a novel PET-probe for the detection of small PSMA positive lesions.
    J Nucl Med. 2018 Nov 2. pii: jnumed.118.218495. doi: 10.2967/jnumed.118.218495.
    PubMed     Text format     Abstract available

  30. ZHUANG M, Vallez Garcia D, Kramer GM, Frings V, et al
    Variability and repeatability of quantitative uptake metrics in [(18)F]FDG PET/CT imaging of non-small cell lung cancer: impact of segmentation method, uptake interval, and reconstruction protocol.
    J Nucl Med. 2018 Nov 2. pii: jnumed.118.216028. doi: 10.2967/jnumed.118.216028.
    PubMed     Text format     Abstract available

  31. LU Y, Sweiss N
    Role of (18)F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring: Addition to the Expert Consensus.
    J Nucl Med. 2018 Nov 9. pii: jnumed.118.221549. doi: 10.2967/jnumed.118.221549.
    PubMed     Text format    

  32. DMOCHOWSKA N, Tieu W, Keller M, Wardill H, et al
    Immuno-PET of innate immune markers CD11b and IL-1beta detect inflammation in murine colitis.
    J Nucl Med. 2018 Nov 9. pii: jnumed.118.219287. doi: 10.2967/jnumed.118.219287.
    PubMed     Text format     Abstract available

  33. VAN BERKEL A, Vriens D, Visser E, Janssen M, et al
    Metabolic subtyping of pheochromocytoma and paraganglioma by (18)F-FDG pharmacokinetics using dynamic PET/CT scanning.
    J Nucl Med. 2018 Nov 9. pii: jnumed.118.216796. doi: 10.2967/jnumed.118.216796.
    PubMed     Text format     Abstract available

  34. YOUSSEF M, Matthews R
    Nuclear Medicine Board Review: Questions and Answers for Self-Assessment, 4th Edition.
    J Nucl Med. 2018 Nov 9. pii: jnumed.118.223172. doi: 10.2967/jnumed.118.223172.
    PubMed     Text format    

  35. ITO K, Teng R, Schoder H, Humm JL, et al
    F-18 FDG PET/CT for monitoring of ipilimumab therapy in patients with metastatic melanoma.
    J Nucl Med. 2018 Nov 9. pii: jnumed.118.213652. doi: 10.2967/jnumed.118.213652.
    PubMed     Text format     Abstract available


    Nucl Med Commun

  36. OKADA Y, Shiraishi M, Nakamura H, Maki F, et al
    Usefulness of the combination of iodine-123-metaiodobenzylguanidine scintigraphy and iodine-123-ioflupane scintigraphy in new-onset Parkinson's disease.
    Nucl Med Commun. 2018;39:983-988.
    PubMed     Text format     Abstract available

  37. ABUQBEITAH M, Demir M, Kabasakal L, Cavdar I, et al
    Indirect assessment of the maximum empirical activity (250 mCi) with respect to dosimetry concepts in radioiodine therapy of metastatic differentiated thyroid cancer.
    Nucl Med Commun. 2018;39:969-975.
    PubMed     Text format     Abstract available

  38. DEMIRCI E, Kabasakal L, Sahin OE, Akgun E, et al
    Can SUVmax values of Ga-68-PSMA PET/CT scan predict the clinically significant prostate cancer?
    Nucl Med Commun. 2018 Nov 2. doi: 10.1097/MNM.0000000000000942.
    PubMed     Text format     Abstract available


    Phys Med Biol

  39. CHEN Y, Vastenhouw B, Wu C, Goorden MC, et al
    Optimized image acquisition for dopamine transporter imaging with ultra-high resolution clinical pinhole SPECT.
    Phys Med Biol. 2018;63:225002.
    PubMed     Text format     Abstract available


    PLoS One

  40. KLYUZHIN IS, Fu JF, Hong A, Sacheli M, et al
    Data-driven, voxel-based analysis of brain PET images: Application of PCA and LASSO methods to visualize and quantify patterns of neurodegeneration.
    PLoS One. 2018;13:e0206607.
    PubMed     Text format     Abstract available


    Semin Nucl Med

  41. PAYCHA F, Gnanasegaran G, Van den Wyngaert T
    Letter from the Guest Editors.
    Semin Nucl Med. 2018;48:395.
    PubMed     Text format    

  42. FREEMAN LM, Blaufox MD
    Letter from the Editors.
    Semin Nucl Med. 2018;48:393.
    PubMed     Text format    


    Synapse

  43. BHATT S, Hillmer AT, Nabulsi N, Matuskey D, et al
    Evaluation of (-)-[(18) F]Flubatine-specific binding: Implications for reference region approaches.
    Synapse. 2018;72.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: